Effect of Tramadol on Postoperative Sore Throat After General Anesthesia
Launched by AFFILIATED CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE · Aug 4, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how effective tramadol, a pain medication, is at reducing sore throat symptoms that often occur after thyroid surgery when a breathing tube is used during general anesthesia. Many patients experience discomfort from a sore throat after the procedure, and the researchers aim to see if tramadol can help improve this situation.
To participate in this study, you need to be a female patient aged between 65 and 74, scheduled for a specific type of thyroid surgery, and in generally good health (as defined by a certain medical classification). You'll be asked to sign a consent form agreeing to join the trial. If you have a history of certain medical conditions, previous surgeries, or are pregnant, you may not be eligible. If you choose to participate, you can expect to receive tramadol and be monitored for any changes in your sore throat after surgery. This trial is currently recruiting participants, so it’s a great opportunity to contribute to understanding better pain management after surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Female with American Society of Anesthesiologists (ASA) physical status I-II; Elective thyroidectomy(non-endoscopic) with endotracheal intubation; The patient signed the consent form.
- Exclusion Criteria:
- • - History of thyroid surgery A history of preoperative sore throat; Pregnancy; Retrosternal goiter; Thyroid tumor invading trachea need trachea reconstruction; Potentially difficult airway; Clinical diagnosis of chronic sore throat; Clinical diagnosis of psychosis; Tracheotomy after operation; Transfer to intensive care unit after operation; Contraindications to tramadol; Body mass index (BMI) \> 30kg/m\^2.
About Affiliated Cancer Hospital Of Shantou University Medical College
The Affiliated Cancer Hospital of Shantou University Medical College is a leading institution dedicated to advancing cancer research and treatment. With a commitment to innovative clinical trial methodologies, the hospital integrates cutting-edge medical practices with comprehensive patient care. As a prominent center for oncology, it collaborates with multidisciplinary teams to enhance therapeutic strategies and improve patient outcomes. The hospital's research initiatives are designed to translate scientific discoveries into effective clinical applications, positioning it at the forefront of cancer treatment and providing invaluable contributions to the global oncology community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shantou, Guangdong, China
Patients applied
Trial Officials
zegeng su, master
Principal Investigator
Affiliated Cancer Hospital of Shantou University Medical College Medical
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials